Fungal Diversity is a premier academic journal dedicated to advancing the science of mycology, encompassing ecological, evolutionary, and biological research involving fungi. Published by Springer, this journal has established a significant presence in the academic community since its inception in 1998, and it continues to thrive with a convergence period extending to 2024. Holding a prestigious Q1 ranking in several categories — including Ecology, Ecology, Evolution, Behavior and Systematics, and Plant Science — Fungal Diversity showcases cutting-edge research that influences ecological management, conservation, and biodiversity studies. With its notable positions in Scopus rankings, including being ranked #1 in Environmental Science - Ecology, the journal serves as an essential resource for researchers, professionals, and students interested in the complex interplay between fungi and their environments. Although it does not currently offer open access, interested readers can benefit from the journal's rich repository of peer-reviewed articles, making Fungal Diversity a vital component of the scientific literature landscape.

The New Zealand Journal of Botany, published by the esteemed Taylor & Francis Ltd, serves as a pivotal platform for disseminating significant research in the fields of Ecology, Evolution, Behavior and Systematics, as well as Plant Science. With a rich history dating back to 1963 and an impressive convergence extending to 2024, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the complexities of plant life and ecological systems in New Zealand and beyond. The journal is currently categorized in the Q3 quartile for both relevant disciplines as of 2023, reflecting its balanced influence within the global academic community. Although not an open access journal, it retains a significant impact factor, evidenced by its Scopus rankings, which place it within the top half of its categories. This makes it an invaluable tool for students, researchers, and academics aiming to engage with robust, peer-reviewed scientific findings and contribute to the evolving discourse surrounding botany and ecological research.

STUDIES IN MYCOLOGY is a premier journal dedicated to advancing research in the field of mycology, published by the renowned WESTERDIJK FUNGAL BIODIVERSITY INSTITUTE. With an impact factor that places it in the top quartile (Q1) of both Agricultural and Biological Sciences and Plant Science categories, it holds a prestigious position in the scientific community, ranking #1 out of 193 in its field as per Scopus metrics. Since its transition to Open Access in 2008, it has made significant strides in disseminating high-quality research widely, fostering a greater understanding of fungal biodiversity and its ecological impact. Covering a broad spectrum of topics related to mycology, the journal aims to provide researchers, professionals, and students with a platform for sharing innovative findings, stimulating academic discourse, and promoting collaborative efforts within this vital area of study. Hailing from the Netherlands, STUDIES IN MYCOLOGY serves as an invaluable resource for exploring the complexities of fungi, their interactions with various ecosystems, and their practical applications in agriculture and beyond.

Current Fungal Infection Reports is an essential academic journal dedicated to the rapidly evolving field of mycology, specifically focusing on the diagnosis, treatment, and epidemiology of fungal infections. Published by Springer, this journal aims to provide a comprehensive platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings and insights into the complexities surrounding fungal diseases. With an ISSN of 1936-3761 and an E-ISSN of 1936-377X, the journal is recognized in the Q3 category for Infectious Diseases as of 2023 and holds a Scopus rank of #199 out of 344 in its field, showcasing its growing influence. Although not currently open access, Current Fungal Infection Reports remains an important resource for those wishing to stay updated on key developments and trends within this critical area of global health. Through its commitment to advancing knowledge and fostering academic exchange, the journal plays a crucial role in combating the challenges posed by fungal infections, making it a must-read for anyone involved in infectious disease research and treatment.

MYCOLOGIA, published by Taylor & Francis Inc, is a prestigious journal that has been at the forefront of fungal research since its inception, with converging years of publication from 1945 to 2024. This interdisciplinary journal, identified by ISSN 0027-5514 and E-ISSN 1557-2536, stands out in various scientific categories, achieving Q1 rankings in Ecology, Evolution, Behavior and Systematics, as well as Plant Science, alongside strong performances in Cell Biology and Molecular Biology categories. With an impact factor that reflects its significance in the field, MYCOLOGIA appeals to a diverse audience, including researchers, professionals, and students dedicated to advancing the understanding of fungal biology and its ecological implications. Notably, while it does not currently operate under an Open Access model, the journal remains a vital resource for those pursuing groundbreaking discoveries in mycology and related disciplines.

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

Journal of Fungi is a premier open-access journal published by MDPI, dedicated to advancing the understanding of fungal biology in its myriad forms. Since its inception in 2015, it has become a vital resource in the fields of ecology, evolution, and plant sciences, attaining notable rankings in Scopus, including Q1 status in Ecology, Evolution, Behavior and Systematics, and Plant Science, with a Q2 ranking in Microbiology (medical). The journal fosters a collaborative platform for researchers, professionals, and students by providing unrestricted access to high-quality, peer-reviewed articles, which encourages the dissemination of innovative findings and methodologies relevant to fungal research. Designed to cater to a global audience, the Journal of Fungi has established its significance in the scientific community, especially from its base in Switzerland, where it continues to contribute to the ongoing discourse in mycology and beyond. With its commitment to open access since its launch and its continuous support for groundbreaking research, the journal plays a crucial role in driving forward the scientific inquiry and ecological awareness in fungal studies.

CRYPTOGAMIE MYCOLOGIE is a prestigious journal published by ADAC-CRYPTOGAMIE dedicated to the study of mycology within the context of ecology, evolution, and biodiversity. With an ISSN of 0181-1584 and an E-ISSN of 1776-100X, this journal is recognized for its significant contributions to advancing knowledge in the field, holding a Q1 ranking in the 2023 Ecology, Evolution, Behavior and Systematics category on Scopus, placing it within the top tier of scholarly publications. Since its inception, with publication years converging from 1990 to 1993 and then from 1995 to 2024, it has served as a vital resource for researchers, professionals, and students alike, offering the latest findings, reviews, and methodologies in mycology. Despite being published without open access options, the journal maintains a strong academic standard and impact factor, established through a rigorous peer-review process. The journal is based in Paris, France, and aims to foster interdisciplinary research that bridges gaps between mycology and related ecological fields.

MYCOBIOLOGY is an esteemed open-access journal published by Taylor & Francis Ltd, specializing in the fields of Infectious Diseases, Microbiology, and Plant Science. Since its inception, the journal has provided a platform for innovative research, showcasing a diverse range of studies that delve into the complexities of mycology and its vast implications on health, agriculture, and the environment. With a commendable impact factor and a Q2 ranking in Plant Science as of 2023, MYCOBIOLOGY facilitates the dissemination of vital findings to a global audience of researchers, professionals, and students. In addition to its commitment to high-quality content, MYCOBIOLOGY has embraced open access since 2018, ensuring that the latest advancements in mycological research are readily available to the academic community and the public. By bridging gaps in knowledge and fostering collaboration across disciplines, MYCOBIOLOGY plays a crucial role in advancing our understanding of fungal biology and its myriad applications.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.